Nixon Peabody
Premier Valley
You are here:  Home  >  Biotech  >  Current Article

Atara shares soar after beating analyst estimates

By   /   Thursday, November 7th, 2019  /   Comments Off on Atara shares soar after beating analyst estimates

    Print       Email
Atara Biotherapeutics shares rose more than 10 percent in early trading Nov. 7, after the company announced new filings and spending that came in lower than analyst expectations for the third quarter. The Thousand Oaks biotech firm said it had a net loss of around $72 million for the quarter ended Sept. 30, up from…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Special on real estate as Buellton Albertsons sells for nearly $19 million

Read More →